TrialJournal for immunotherapy of cancer2024

Neoadjuvant toripalimab combined with axitinib in patients with locally advanced clear cell renal cell carcinoma: a single-arm, phase II trial.

Jiwei Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.